Understanding the Mental Health of Migrant Workers During the COVID-19 Outbreak

Mental Health Issue Clinical Trial

Official title:

Understanding the Mental Health of Migrant Workers During the COVID-19 Outbreak

Clinical Trial Details — Status: Completed

Administrative data

• NCT number: NCT04448704
• Other study ID #: CCF@EXPO/R001/2020
• Status: Completed
• Start date: June 22, 2020
• Est. completion date: October 11, 2020

Study information

• Verified date: January 2023
• Source: Yale-NUS College
• Contact: n/a
• Is FDA regulated: No
• Study type: Observational

Clinical Trial Summary

This study aims to evaluate the mental health impact of the COVID-19 pandemic on international migrant workers by (1) documenting mental health symptoms among migrant workers and (2) identifying risk and protective factors during the pandemic.

Description:

Worldwide, there are an estimated 164 million migrant workers. Although studies have documented how migrant workers have an increased risk of adverse mental health outcomes, little is known about their mental health burden during a large-scale health crisis.

In the current COVID-19 outbreak, migrant workers represent 9 in 10 of the COVID-19 cases in Singapore, with 25 dormitories gazetted to contain the spread of the virus. Correspondingly, these measures have placed a spotlight on the mental well-being of migrant workers.

In this research protocol, the investigators propose to administer a survey to understand the prevalence and predictors of mental health symptoms amongst migrant workers in Singapore. In particular, prior meta-analyses have identified COVID-19 health concerns, quarantine status, financial instability, exposure to news and misinformation and demographics (i.e., gender, age, education) as risk factors for poor mental health amongst the general population. By assessing these factors amongst the migrant worker population and documenting their impact on migrant workers' mental health, we hope to identify workers in greatest need of support during the ongoing pandemic and provide empirical evidence to guide public health policies.

Recruitment information / eligibility

• Status: Completed
• Enrollment: 1011
• Est. completion date: October 11, 2020
• Est. primary completion date: October 11, 2020
• Accepts healthy volunteers: Accepts Healthy Volunteers
• Gender: All
• Age group: 21 Years and older

Eligibility

Inclusion Criteria:

• =21 years of age

• Hold a government-issued work permit identifying employment status

Related Conditions & MeSH terms

• Mental Health Issue

Locations

Country	Name	City	State
Singapore	EXPO	Singapore

Sponsors (1)

Lead Sponsor	Collaborator
Yale-NUS College

Country where clinical trial is conducted

Singapore, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	DASS-21 Scores	Depression, Anxiety and Stress Scale (DASS-21) is a validated 21-item measure that has been widely used during the current COVID-19 pandemic.	single measurement upon study enrolment